Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCOAST: Prasugrel Pretreatment in NSTEMI
NCT01015287Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of prasugrel in non-ST elevation myocardial infarction (NSTEMI), sponsored by Eli Lilly and Company. Started Dec 2009; status: completed.
02
Drugs
prasugrel
03
Conditions
non-ST elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT01015287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015287.